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PURPOSE. Neurofibromatosis type 1 (NF1) is the result of inherited mutations in the NF1
tumor suppressor gene, which encodes the protein neurofibromin. Eye manifestations are
common in NF1 with recent reports describing a vascular dysplasia in the retina and
choroid. Common features of NF1 retinopathy include tortuous and dilated feeder vessels
that terminate in capillary tufts, increased endothelial permeability, and neovasculariza-
tion. Given the retinal vascular phenotype observed in persons with NF1, we hypothesize
that preserving neurofibromin may be a novel strategy to control pathologic retinal
neovascularization.
METHODS. Nf1 expression in human endothelial cells (EC) was reduced using small hairpin
(sh) RNA and EC proliferation, migration, and capacity to form vessel-like networks were
assessed in response to VEGF and hypoxia. Wild-type (WT), Nf1 heterozygous (Nf1þ/), and
Nf1flox/þ;Tie2cre pups were subjected to hyperoxia/hypoxia using the oxygen-induced
retinopathy model. Retinas were analyzed quantitatively for extent of retinal vessel dropout,
neovascularization, and capillary branching.
RESULTS. Neurofibromin expression was suppressed in response to VEGF, which corresponded
with activation of Mek-Erk and PI3-K-Akt signaling. Neurofibromin-deficient EC exhibited
enhanced proliferation and network formation in response to VEGF and hypoxia via an Akt-
dependent mechanism. In response to hyperoxia/hypoxia, Nf1þ/ retinas exhibited increased
vessel dropout and neovascularization when compared with WT retinas. Neovascularization
was similar between Nf1þ/ and Nf1flox/þ;Tie2cre retinas, but capillary drop out in
Nf1flox/þ;Tie2cre retinas was significantly reduced when compared with Nf1þ/ retinas.
CONCLUSIONS. These data suggest that neurofibromin expression is essential for controlling
endothelial cell proliferation and retinal neovascularization and therapies targeting neuro-
fibromin-deficient EC may be beneficial.
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Neurofibromatosis type 1 (NF1) is the most commonautosomal dominant tumor predisposition syndrome and
affects 1 in 2500 persons worldwide.1 Inactivating mutations in
the NF1 tumor suppressor gene cause NF1. Neurofibromin, the
product of NF1, functions as a GTP-ase activating protein (GAP)
for p21Ras (Ras) and suppresses RAS activity by enhancing the
slow intrinsic hydrolysis of active GTP-Ras. Thus, neuro-
fibromin-deficient cells exhibit enhanced activity of the Ras-
dependent kinases, Erk and Akt, leading to a prosurvival
phenotype.
Eye manifestations are diagnostic of NF1.2 Lisch nodules (iris
hamartomas) present in early childhood and optic pathway
gliomas (OPG) affect 15% of NF1 patients.3,4 More recently,
abnormalities in the retinal and choroidal vasculature have
been appreciated with an estimated prevalence between 60%
and 100% of persons with NF1.5–11 Retinal capillaries and
feeder vessels appear tortuous and disorganized and are often
found in close proximity to choroidal abnormalities. Similarly,
Shields et al.12,13 have identified an association between retinal
vasoproliferative tumors (RVPT) and NF1, which is often
associated with visual disturbances. Vascular features of RVPT
in NF1 include dilated feeder vessels (100%), edema (100%),
exudation (100%), vitreoretinal hemorrhage (50%), and retinal
neovascularization (30%). Interestingly, the median age of
clinical presentation was 12 years (9–36), which is considerably
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younger than the median age of presentation in non-NF1
patients (45 years).14
Based on the clinical rationale that persons with NF1 are
predisposed to pathologic retinal neovascularization and other
vascular abnormalities, the present study aims to identify
neurofibromin’s function in VEGF-induced endothelial cell
proliferation, migration, and vessel-like network formation and
characterize retinal neovascularization in neurofibromin-defi-
cient mice in response to hyperoxia/hypoxia. Our findings
suggest that neurofibromin expression is critical for limiting
VEGF and hypoxia-induced EC proliferation and vessel-like
network formation via Ras-Akt activation. Using the murine
oxygen-induced retinopathy model, we demonstrate that Nf1
heterozygosity (Nf1þ/) enhances retinal neovascularization
and impairs vascular regrowth. Further, Nf1 heterozygosity in
Tie2þ EC is sufficient to reproduce the enhanced neovascular-
ization observed in Nf1þ/ retinas, but also promotes vascular
regrowth following hyperoxia-induced vaso-obliteration.
METHODS
Human Endothelial Cell Culture
Pooled human endothelial colony forming cells (ECFC,
endothelial outgrowth cells) were purchased from the Angio
BioCore at Indiana University (Principal Investigator: Karen
Pollock, PhD).15 Human microvascular endothelial cells
(HMVEC) were purchased from Lonza (Allendale, NJ, USA).
ECFC and HMVEC were maintained in Endothelial Basal
Medium-2 (EBM2; Lonza) with additives (bullet kit) provided
by the manufacturer. The media was supplemented with 10%
Hyclone FBS (Fisher, Waltham, MA, USA) and 2% penicillin/
streptomycin. All cells were maintained 378C, 5% CO2 at
normoxia unless otherwise stated.
NF1 Gene Silencing
Lentiviral vectors expressing NF1 small hairpin (sh) RNA and
shCtr were purchased from Sigma (CAT# TRCN000023878,
TRCN0000039713, and SHC202; St. Louis, MO, USA). To
generate lentiviral supernatant, 293FT packaging cells were
plated onto tissue culture plates and transfected the following
day using Lipotectamine 3000 (Invitrogen, Carlsbad, CA, USA)
according to manufacturer’s instructions. The transfected cells
were incubated in Dulbecco’s modified Eagle’s Medium
(DMEM; Thermo, Carlsbad, CA, USA) supplemented with
10% FBS. Viral stocks were harvested 24 hours after
transfection, with collection at 48 and 72 hours, clarified by
centrifugation, filtered through a 0.45-lm filter and stored at
80C. Human ECFC were seeded onto tissue culture plates
coated with collagen and transduced with lentiviral stock
diluted at 1:3 to 1:5 with EOC culture medium in the presence
of 8 lg/mL polybrene (Sigma) for 8 hours. Fresh medium was
replaced. At 48 hours posttransduction fresh medium with 0.5
lg/mL puromycin (Thermo) was replaced for 3 days. Selected
cells were subcultured and NF1 knockdown was confirmed by
Western blot.
Reagents
The following antibodies were used: anti-neurofibromin
(#A300; Bethyl Laboratories, Montgomery, TX, USA); anti-
phospho-Akt XP (#4060), anti-Akt (#2938S), anti-phospho-Erk
XP (#4370), anti-Erk (#4695S; Cell Signaling, Danvers, MA,
USA); anti-phospho-endothelial nitric oxide synthase (eNOS)
(612392) and FITC-anti-CD31 (BD Laboratories, San Jose, CA,
USA); and anti-GAPDH (Novus, Littleton, CO, USA). Recombi-
nant human and murine VEGF were purchased from Peprotech
(Rocky Hill, NJ, USA). Wortmannin was purchased from
Cayman Chemicals (Ann Arbor, MI, USA).
BrdU Incorporation
BrdU incorporation into ECFC was performed according to the
manufacturer’s instructions (Millipore, Burlington, MA, USA).
Briefly, ECFC were progressively serum starved (5% FBS for 24
hours, 1% FBS for 7 hours, 0.125% for experiments) prior to
the addition of VEGF (25 ng/mL). Two hours after the addition
of VEGF, media was supplemented with BrdU and cells were
fixed 24 or 48 hours following VEGF stimulation. Fixed cells
were labeled with anti-BrdU monoclonal antibody followed by
a goat anti-mouse IgG Peroxidase Conjugate. Signal intensity
was measured using a spectrophotometer at 450/550 nm
(BMG Labtech, Cary, NC, USA). In some experiments, ECFC
were cultured in sealed chamber with an environmental
oxygen concentration of 1% (ProOx 110; BioSpherix, Parish,
NY, USA).
Vessel-Like Network Formation
The formation of closed vessel-like networks was assessed in
NF1KD and Scr ECFC in response to VEGF as previously
described.16 Briefly, 96-well plates were coated with 30 lL
Matrigel (Corning, NY, USA) and ECFC were seeded at a density
of 10,000 cells per well. Cells were observed every 4 hours
using an inverted microscope (Zeiss, Thornwood, NY, USA). and
three uniform 340 high-power images were captured for each
well. The number of intact vessel-like networks were counted
and averaged per320 high-power field.
Animals
All experiments were approved by the Institutional Committee
for Animal Use in Research and Education and conformed to the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Nf1þ/– mice were obtained from Tyler Jacks
(Massachusetts Institute of Technology, Cambridge, MA, USA)
and backcrossed 13 generations into the C57BL/6J strain.
Nf1flox/flox mice were obtained from Luis Parada (University of
Texas Southwestern Medical Center, Dallas, TX, USA) and
maintained on C57BL/6J background. Tie2cre (4128) and VE-
cadherin cre (VEcre, 6137) mice were purchased from The
Jackson Laboratory (Bar Harbor, ME, USA) and maintained on
C57BL/6J background. Nf1flox/flox mice were crossed with
Tie2cre or VEcre mice to generate Nf1flox/þ;Tie2cre or
Nf1flox/þ;VEcre and Nf1flox/þ (control) mice. Cre-mediated
recombination was confirmed by PCR as previously described.17
Matrigel Plug Assay
Matrigel plugs were incubated with VEGF in the presence or
absence of wortmannin and inserted into wild-type (WT) and
Nf1þ/ mice as previously described.18 Concentrated Matrigel
(Corning) was diluted and mixed with VEGF (100 ng/mL)þ/
wortmannin (25 nM) on ice. WT and Nf1þ/ mice were
anesthetized via inhalation of isoflurane (2%)/oxygen (98%)
mixture. An equal volume of Matrigel was then injected
slowly into the subcutaneous layer on the abdomen of WT
and Nf1þ/ mice. Ten days after Matrigel insertion, animals
were killed and Matrigel plugs were harvested for analysis.
Matrigel plugs were photographed using a digital camera
(Nikon, Tokyo, Japan), fixed in paraformaldehyde, and labeled
with FITC anti-CD31 antibody. Digital images were obtained
using a Zeiss Axioplan 2 Imaging System. Six mice per
condition were used.
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Endothelial Cell Outgrowth From Aortic Rings
Thoracic aortas were isolated from WT and Nf1þ/ mice,
removed of periadventicial fat, and cut into 1-mm rings. Three
aortic rings from each animal were transferred to 24-well
collagen-coated plate and maintained in optimized HMVEC
growth media. Culture media was supplemented with 100 ng/
mL of VEGF (Sigma) and endothelial cell outgrowth was
monitored every other day for 12 days. Aortic rings were
photographed using an inverted microscope with non–phase
contrast optics at day 12 and the number of cells per image
was quantified by a blinded observer and averaged for each
animal. For some experiments, wortmannin (25 nM) was
added to the aortic rings. Aortic rings from three animals per
condition were used.
Oxygen-Induced Retinopathy
Retinopathy was induced in newborn C57Bl/6 mice as
previously described by Smith et al.19 On postnatal day 7
(P7), dams and pups were placed in a sealed chamber in which
the oxygen concentration was maintained at 75% oxygen. At
P12, animals were transferred back to cages maintained in
normoxia (21%). Room temperature was maintained on a 12-
hour light/dark cycle. Newborn pups and dams were provided
standard chow and water ad libitum. Six to seven pups per
litter were used for all experiments.
Analysis of Vessel Dropout and Neovascularization
Animals were killed on P17 and eyeballs were removed and
fixed in 4% paraformaldehyde for analysis. Following fixation,
retinas were isolated, washed in PBS, and retinal flatmounts
prepared. Retinal tissue was permeablized in 10% Triton X-100
(Sigma) and incubated with isolectin GS-1B4 Alexa Fluor 594
(Fisher, Waltham, MA, USA) in the dark overnight at 48C.
Retinas were placed on glass slides, incubated in Vectashield
mounting media (Vector Labs, Burlingame, CA, USA) and digital
images were acquired using a Zeiss Axioplan 2 Imaging System.
Digital images were assembled using Photoshop (Adobe
Systems, Inc., San Jose, CA, USA) for further analysis. Central
vessel dropout area was quantified from the digital images
using the ImageJ software (http://imagej.nih.gov/ij/; provided
in the public domain by the National Institutes of Health,
Bethesda, MD, USA) and neovascular area was determined
using the Swift_NV macro for ImageJ.20 Branching was also
determined by counting terminal cells proximal to the central
vessel dropout zone.
Statistical Analysis
The results of cell culture experiments are presented as mean
6 SEM. Vessel dropout, neovascular area, and branching are
presented as mean 6 SD. Endothelial cell BrdU incorporation,
vessel-like network formation, vessel dropout, neovascular
area, and branching were compared by two-way ANOVA with
Tukey’s post hoc test for multiple comparisons. Analysis was
performed using GraphPad Prism version 6.0h (La Jolla, CA,
USA). P < 0.05 was considered significant.
RESULTS
Neurofibromin Regulates VEGF Signaling in EC
Activation of the RTK VEGFR2 leads to phosphorylation of the
Ras kinases, Erk and Akt; however, the role of neurofibromin in
regulating VEGF/VEGFR2 signaling is poorly understood.
Incubation of human ECFC (Fig. 1A) with VEGF reduced
neurofibromin protein expression in confluent and subcon-
fluent (60%–70%) ECFC (Figs. 1B, 1C). These observations
corresponded with enhanced phosphorylation of Akt and Erk
kinases. Expression of total Erk and Akt were unchanged (data
not shown). A similar molecular signature was observed in
HMVEC (Fig. 1D). In both cell types, neurofibromin expression
was decreased transiently in response to VEGF and neuro-
fibromin expression was fully restored by 30 minutes after
VEGF treatment, which corresponded with blunting of Erk and
Akt phosphorylation (data not shown).
Nf1 Knockdown Activates Ras and Enhances EC
Proliferation and Vessel-Like Network Formation
Using two shRNA constructs targeting the Nf1 gene, we show
that decreased neurofibromin expression in ECFC (NF1KD)
does not enhance Erk or Akt phosphorylation in the absence of
growth factor stimulation (Fig. 2A). For subsequent experi-
ments, we elected to use shNF1 (NF1KD). In response to
VEGF, NF1KD ECFC exhibit enhanced Erk phosphorylation as
compared with shCtr ECFC. On the other hand, phosphory-
lation of Akt appears to be similar between shCtr and NF1KD
ECFC, which is consistent with preferential activation of
canonical Ras-Erk signaling in neurofibromin-deficient cells.
Next, we treated Nf1KD ECFC with VEGF and examined EC
proliferation using BrdU incorporation. NF1KD ECFC exhibit-
ed a time-dependent increase in BrdU incorporation when
compared with shCtr ECFC (Figs. 2B, 2C). Similarly, vessel-like
network formation was enhanced in NF1KD ECFC when
compared with shCtr ECFC, which is completely blocked by
treatment of NF1KD ECFC with the PI3-K-Akt inhibitor
wortmannin (Figs. 2D, 2E).
Hypoxia and VEGF Exert Additive Effects on
NF1KD ECFC Proliferation
Ischemic retinopathy is the pathologic consequence of
perturbations in VEGF expression and activity, coupled with
a relative oxygen gradient, leading to disruptions in EC
proliferation and capillary formation. Because VEGF markedly
increased proliferation and vessel-like network formation in
NF1KD ECFC, we used BrdU incorporation to assess ECFC
proliferation in response to hypoxia and/or VEGF. NF1KD
ECFC exhibits a modest, but nonsignificant proliferative
advantage over shCtr ECFC (Fig. 3). However, hypoxia (1%)
exposure and VEGF amplified proliferation in NF1KD ECFC
when compared with Scr ECFC. Together, VEGF and hypoxia
synergistically enhance proliferation in NF1KD ECFC. A similar,
but more modest trend, was observed in shCtr ECFC.
Nf1þ/ EC Angiogenic Sprouting is Enhanced by
VEGF
Based on our observation that VEGF suppresses neurofibromin
expression and that NF1KD ECFC proliferation and vessel-like
network formation is significantly increased in NF1KD ECFC
when compared with shCtr ECFC, we isolated thoracic aortic
rings to examine EC outgrowth in response to VEGF. EC
outgrowth was significantly higher in Nf1þ/ aortic rings
stimulated with VEGF when compared with WT aortic rings
stimulated with VEGF (Figs. 4A, 4B). Suppression of Akt
phosphorylation with wortmannin effectively blocked EC
outgrowth from Nf1þ/ aortic rings (Figs. 4A, 4B). Next, we
used the Matrigel plug assay to confirm these observations.
Matrigel supplemented with VEGF (100 ng/mL) were implant-
ed into the subcutaneous layer of Nf1þ/ and WT mice. In
response to VEGF, Matrigel plugs harvested from Nf1þ/ mice
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were invested with more CD31-positive vessel-like networks
when compared with Matrigel plugs harvested from WT mice
(Fig. 4C).
Vessel Dropout and Neovascularization are
Increased in Nf1þ/ Mice
Human studies strongly suggest that NF1 patients exhibit
pathologic retinal vasculature, endothelial cell overgrowth, and
neovascularization. A preclinical model of NF1 retinopathy has
not been developed. Therefore, we used the oxygen-induced
retinopathy model to assess retinal neovascularization and
vessel dropout in Nf1þ/ and WT mice. Examination of P9
retinas from Nf1þ/ and WT mice raised in normoxia (21%)
revealed a complete network of superficial retinal vessels in
both genotypes (data not shown). However, exposure to
hyperoxia from P7 to P12 increased central vessel dropout area
and enhanced neovascularization in Nf1þ/ mice at P17 when
compared with WT mice (Figs. 5A–C). Neovascular tufts were
noted to be approximate to the line of demarcation between
the vascular and avascular retina in WT mice. In contrast,
neovascularization appeared more diffuse in Nf1þ/ retinas.
The number of branching capillaries adjacent to the avascular
retina was increased in Nf1þ/ mice when compared with WT
mice (Figs. 6A, 6B).
Deletion of Nf1 in Tie2þ Cells Enhances
Neovascularization and Reduces Vessel Dropout
Based on our observation that Nf1þ/ retinas have increased
vessel dropout and neovascularization, features that are seen in
NF1 patients, we used Cre/lox technology to delete Nf1 in
Tie2þ EC and examine retinal vasculature in the oxygen-
induced retinopathy (OIR) model. Similar to previous pub-
lished reports, homozygous deletion of Nf1 in Tie2þ cells
results in midgestation lethality. Therefore, we used
Nf1flox/þ;Tie2cre animals, which express a single Nf1 mutation
in Tie2þ EC and monocytes/macrophages. Similar to Nf1þ/ and
WT mice, a complete network of superficial retinal vessels was
observed in Nf1flox/þ;Tie2cre at P9 (data not shown). In
response to hyperoxia/hypoxia, Nf1flox/þ;Tie2cre retinas ex-
hibited increased neovascularization, which was similar
qualitatively and quantitatively to Nf1þ/ retinas (Figs. 7A–C).
In contrast to Nf1þ/ retinas, central vessel dropout was
markedly reduced in Nf1flox/þ;Tie2cre and more closely
resembled WT retinas (Figs. 7A, 7B).
Deletion of Nf1 in VE CadherinþCells Recapitulates
Nf1þ/ Phenotype
Based on the observation that Nf1 deletion in Tie2þ cells did
not fully recapitulate the phenotype observed in Nf1þ/ retinas,
we intercrossed Nf1flox/flox and VEcre animals to generate
Nf1flox/þ;VEcre offspring and subjected pups to OIR. In
response to OIR, Nf1flox/þ;VEcre retinas exhibited increased
neovascularization and vessel dropout, which closely resem-
bled our observations in Nf1þ/ animals (Figs. 8A, 8B).
DISCUSSION
A growing body of evidence supports the hypothesis that Ras
activation is crucial for retinal neovascularization and targeting
Ras kinases directly or indirectly has proven efficacious in
animal models of oxygen-induced retinopathy.21–24 Erk and
FIGURE 1. Neurofibromin is a negative regulator of VEGF signaling in endothelial cells. (A) Phenotypic characterization of ECFC showing positive
and negative selection markers consistent with classification as EC. (B, C) Representative Western blots (B) and quantitative densitometry (C)
showing neurofibromin expression in response to VEGF (25 ng/mL) in subconfluent and confluent ECFC and HMVEC, n¼ 3. (D) Representative
Western blots showing neurofibromin expression and phosphorylation of Akt, Erk, and eNOS (1177) in response to VEGF in ECFC and HMVEC, n¼
3.
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Akt, the principal downstream kinases that mediate Ras
signaling, are activated in retinal and nonretinal EC in response
to VEGF and their activation is essential for VEGF-induced EC
proliferation, migration, and vessel-like network forma-
tion.25–28 Further, phosphorylated Erk colocalizes with
VEGFR2 in sprouting endothelial cells during retinal neovas-
cularization and pharmacologic inhibition of Erk kinase and the
Akt-mTOR pathway suppresses retinal neovascularization
FIGURE 2. NF1 silencing enhances Ras signaling endothelial cell function. (A) Representative Western blot confirming NF1 gene silencing (NF1KD)
and Akt and Erk activation in the presence or absence of VEGF (25 ng/mL). (B, C) BrdU incorporation (B) and photomicrographs (C) of control
(white bars) and NF1KD (black bars) ECFC in response to VEGF (25 ng/mL) over 48 hours. Data represent mean 6 SEM, *P < 0.01, **P < 0.001, n
¼ 3. (D, E) VEGF-induced vessel-like network formation (D) and quantification (E) at 12 hours in control and NF1KD ECFC in the presence or
absence of wortmannin (10 nM), n¼ 3 in triplicate.
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during oxygen-induced retinopathy.22,25,29,30 Thus, Ras signal-
ing mediates the effects of VEGF during the neovascular phase
of OIR when VEGF expression is rapidly upregulated and Ras
activation is essential for sprouting angiogenesis.
Neurofibromin interacts with WT H-, N-, and K-Ras via its
GTP-ase regulatory domain (GRD) and serves as a molecular
switch for Ras by stabilizing Ras in its diphosphate (inactive)
conformation. Thus, neurofibromin suppresses Ras signaling in
response to extracellular growth factors, including VEGF, and
loss of neurofibromin permits Ras signaling to proceed
unchecked. In the present study, we provide the first direct
evidence that suppression of neurofibromin is an intermediate
step in VEGF activation of the Ras kinases Erk and Akt in
circulating and microvascular EC. The transient nature of
decreased neurofibromin expression and temporal relationship
with the active conformations of Erk and Akt suggests that
VEGF-induced Ras activation is tightly regulated by neuro-
fibromin. Growth factor–induced suppression of neurofibro-
min is the result of protein kinase C (PKC)-mediated
ubiquitination and proteasomal degradation.31 Interestingly,
PKC overexpression, which enhances neurofibromin degrada-
tion, increases retinal neovascularization while genetic dele-
tion or pharmacologic inhibition of PKC prevents retinal
neovascularization in OIR.32,33 Suppression of neurofibromin
permits VEGF-mediated Ras activation and restoration of
neurofibromin expression is necessary to turn off VEGF
signaling. These relationships are perturbed in persons with
NF1 who fail to express full length, active neurofibromin as
evidenced by the enhanced proliferation observed in NF1KD
ECFC in response to VEGF and/or hypoxia. The inability to
turn off VEGF-Ras signaling in the setting of neurofibromin-
deficiency contributes to uncontrolled EC proliferation and
angiogenesis and likely contributes to retinal neovasculariza-
tion, which is highly prevalent in persons with NF1.
Molecular targeting of Ras kinase activity is particularly
attractive in the prevention or treatment of neovascularization
with emerging evidence suggesting this approach is both
plausible and efficacious.30,34–37 Ras is active in sprouting
retinal EC and appears to be suppressed in quiescent retinal EC
during neovascularization.22 Interestingly, expression of
p120RasGAP, a protein that suppresses Ras activity, is poorly
expressed in VEGFR2-expressing tip EC during neovascular tuft
formation, but is readily expressed after peak tuft formation,
which suggests that Ras is tightly regulated during retinal
neovascularization.22 Our observation that VEGF suppresses
neurofibromin expression and this suppression corresponds
closely with Erk and Akt activation as well as EC proliferation
lends support to this hypothesis because vitreoretinal VEGF
expression surges during the neovascular phase of OIR. While
pharmacologic inhibition of canonical Ras-Erk signaling im-
pairs neurofibromin-deficient EC proliferation, noncanonical
activation PI3-K-Akt signaling in these cells is completely
unexplored. Similar to increased Erk kinase activity in
proliferating retinal EC, Akt expression is upregulated in the
hypoxic phase of OIR and administration of an Akt inhibitor
during this phase suppresses retinal neovascularization.38
Additionally, Akt phosphorylates eNOS and eNOS expression
and activity is temporally related to hyperoxia and hypoxia in
the formation of retinal neovascular tufts.39–41 Our observation
that the PI3-K-Akt inhibitor wortmannin suppresses vessel-like
network formation and prevents EC sprouting from Nf1þ/
aortic rings suggests that Akt activation is a critical step for
neurofibromin-deficient EC proliferation, migration, and capil-
lary formation. However, Erk is also activated in NF1KD ECFC
and previous studies by our group and others have suggested
that pharmacologic inhibition of canonical Ras-Erk signaling
impairs neurofibromin-deficient EC proliferation and migra-
tion.27,42 Interestingly, Ismat et al.43 showed that canonical Ras-
Erk signaling is constitutively active and Ras-Akt signaling is
suppressed in Nf1 knockout EC. Expression of the GRD in Nf1
knockout EC suppressed Erk activity and, conversely, en-
hanced Akt phosphorylation, which demonstrates the close
and sometimes opposing relationship between these two
pathways.
While our data demonstrate that NF1KD ECFC are highly
proliferative and exhibit enhanced angiogenic capacity, we also
recognize that stromal cells may influence neurofibromin-
deficient EC proliferation and neovascularization in Nf1þ/
FIGURE 3. Hypoxia and VEGF exert additive effect on NF1KD ECFC
proliferation. BrdU incorporation in control (white bars) and NF1KD
(black bars) ECFC in response to VEGF (25 ng/mL) in ambient (21%)
and hypoxic (1%) environment. Data represent mean 6 SEM, *P <
0.05, **P < 0.01, n ¼ 3.
FIGURE 4. VEGF enhances vascular sprouting in Nf1þ/ mice and aortas via the Ras-PI-3kinase pathway. (A, B) Photomicrographs (A) and
quantification (B) of EC outgrowth from aortic rings isolated from WT (white bars) and Nf1þ/ (black bars) mice in response to VEGF in the
presence/absence of wortmannin (10 nM). Data represent mean 6 SEM, *P < 0.01, n¼ 3 in triplicate. (C) Photograph and confocal imaging of anti-
CD31 staining of Matrigel plugs containing VEGF inserted into WT and Nf1þ/ mice.
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mice. NF1 gene silencing in Schwann cells, the principal cells
in neurofibromas (pathognomonic tumor of NF1), increases
VEGF secretion and promotes angiogenesis in Nf1þ/
mice.27,44–46 These vascular tumors are characterized by high
expression of VEGF and VEGFR2, which provides a clinical
rationale for the use of anti-VEGF antibodies and VEGFR2
inhibitors for neurofibromas. Our own observations may
suggest that loss of neurofibromin in stromal cells enhances
angiogenesis and neovascularization. EC sprouting is increased
in aortic explants from Nf1þ/ mice and capillary formation
was enhanced in Matrigel plugs implanted into Nf1þ/ mice,
which may be the result of cues from Nf1þ/ stromal cells and
circulating hematopoietic cells to induce Nf1þ/ EC prolifera-
tion. In this regard, monocytes and macrophages are intriguing
support cells for angiogenic EC and retinal neovascularization.
Macrophages are abundant in the retina during the hypoxia
phase of OIR and are critical for pathologic neovasculariza-
tion.47–49 Nonselective depletion of macrophages has a
protective effect against neovascular tuft formation.50 This
line of thinking is intriguing because we recently demonstrated
that neurofibromin is a master regulator of macrophage
differentiation and neurofibromin-deficient macrophages ex-
hibit a prosurvival phenotype characterized by enhanced
proliferation, migration, adhesion, and secretion of growth
factors and reactive oxygen species.51–54 Further, the similar-
ities/differences in neovascular tuft formation between Nf1þ/
and Nf1flox/þ;Tie2cre retinas in response to hyperoxia/hypoxia
may be explained by the presence of the Tie2 promoter in both
EC and macrophages.55–57 Deletion of Nf1 in macrophages
increases ROS production and growth factor secretion, which
may lead to excessive proliferation of neurofibromin-deficient
retinal EC.52,53 Thus, the neovascular phenotype observed in
Nf1þ/ and Nf1flox/þ;Tie2cre retinas may be explained by a
cooperation between infiltrating neurofibromin-deficient mac-
rophages and/or resident microglia and angiogenic EC to
promote pathologic angiogenesis at the expense of retinal
revascularization. Based on the overlapping expression of Tie2
in both EC and hematopoietic cells, we intercrossed the
Nf1flox/flox mice with mice expressing Cre under the VE
cadherin promoter (VECre). These mice are generally accepted
FIGURE 5. Vessel dropout and neovascular area are increased in Nf1þ/
retinas. (A) Representative photomicrograph of P17 retinal flat mounts
isolated from WT and Nf1þ/mice. Central vessel dropout is outlined in
yellow. Yellow arrows indicate neovascular tufts. (B, C) Quantification
of percent vessel dropout (A) and neovascular area (B) in WT (white
bars) and Nf1þ/ (black bars) retinas. Data represent mean 6 SD, n¼
10–12 per group.
FIGURE 6. Branching is enhanced in Nf1þ/ retinas. (A) Representative
high-power photomicrograph of P17 retinal flat mounts isolated from
WT and Nf1þ/ mice. Yellow arrows indicate angiogenic sprouts. (B)
Quantification of branching in WT (white bar) and Nf1þ/ (black bar)
retinas. Data represent mean 6 SD, n¼ 10–12 per group.
FIGURE 7. Heterozygous deletion of Nf1 in Tie2þ cells promotes
retinal neovascularization. (A) Representative photomicrograph of P17
retinal flat mounts isolated from Nf1flox/þ and Nf1flox/þ;Tie2cre mice.
Central vessel dropout is outlined in yellow. Yellow arrows indicate
neovascular tufts. (B, C) Quantification of percent vessel dropout (A)
and neovascular area (B) in Nf1flox/þ (white bars) and Nf1flox/þ;Tie2cre
(black bars) retinas. Data represent mean 6 SD, n¼ 10–12 per group.
FIGURE 8. Heterozygous deletion of Nf1 in VE cadherinþ cells
recapitulates Nf1þ/ phenotype. (A, B) Quantification of percent vessel
dropout (A) and neovascular area (B) in Nf1flox/þ (white bars) and
Nf1flox/þ; VECre (black bars) retinas. Data represent mean 6 SD, n ¼
7–8 per group.
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to be highly EC-specific; however, close examination of the
expression pattern of VE cadherin (also known as, Cdh5) in
both commercially available Cre lines demonstrates that 50% to
95% of circulating hematopoietic cells in adult mice arise from
progenitor cells that at one time expressed VE cadherin.58,59
Thus, while Nf1flox/þ;VECre mice completely recapitulate the
retina phenotype observed in Nf1þ/ mice, cautious interpre-
tation of these results must be taken because Cre expression is
occurring in EC and circulating hematopoietic cells. Ongoing
studies in our laboratory are focused on exploring the
relationship between EC and various hematopoietic cells in
the pathogenesis of OIR.
Here, we demonstrate that neurofibromin functions as a
negative regulator of VEGF signaling in EC. Inactivating
mutations in the NF1 gene confer a proliferative EC
phenotype and impair their ability to turn off extracellular
cues leading to retinal neovascularization and impaired
revascularization. Our findings provide a framework for
interrogating VEGF signaling in the retinal vasculature and
an in vivo platform for the rational design of antiangiogenic
compounds that promote or maintain neurofibromin expres-
sion.
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